KPMA pushes forward with survey on rebate-suspicious companies
The survey over rebate-suspicious companies, which has been postponed due to the government’s announcement of pharmaceutical industry’s promotional policy and certification of innovative pharmaceutical companies, is expected to be pushed forward.
Moreover, since PharmaKing, which was suspended b...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
